08Jun
FDA Signals a Deliberative Approach to Cannabis at Public Hearing
While it was ostensibly convened to gather scientific input from stakeholders on how to appropriately regulate cannabis-infused products, the Food and Drug Administration (FDA) also used the May 31, 2019 public hearing as a platform to issue a call...
By:
Wilson Sonsini Goodrich & Rosati
Related
On February 11, 2020, the Equal Employment Opportunity Commission (EEOC) filed a complaint in Connec...
Read More >
Our monthly edition of the “Government Contracts Regulatory and Legislative Update” offers a summa...
Read More >
Wearable fitness products company Fitbit Inc. announced Friday it entered a definitive agreement to ...
Read More >
Although it was very quiet on the western front (in particular, in California), 2019 was generally a...
Read More >
The Treasury Laws Amendment (Enhancing Whistleblower Protections) Bill 2018 introduced huge reform f...
Read More >
In late February as the COVID-19 pandemic was accelerating, the Delaware Chancery Court issued an im...
Read More >